Symptom Control and Impact on Daily Life in Patients With Gastroesophageal Reflux Disease
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
The purpose of this study is to evaluate the impact of gastroesophageal reflux disease (GERD) treatment in primary care setting on symptom control and daily life in symptomatic GERD patients, using both GERD questionnaire and clinical symptoms assessment
Condition or disease
Gastroesophageal Reflux Disease
A prospective, observational study to describe symptom control and impact on daily life in patients with gastroesophageal reflux disease (GERD)
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years and older (Adult, Senior)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
primary care setting
Patients known or newly diagnosed with GERD
Patients with typical GERD symptoms as heartburn and regurgitation for ≥2 days in the previous week
Patients, currently not treated with a proton pump inhibitor
Patients who have been receiving treatment with non-steroidal antiinflammatory drugs within two weeks prior the inclusion in the study
Patients with medical history of surgery of the esophagus, stomach or duodenum